CD163 and Huntington disease: Considering a subgroup of patients who consented to have follow-up blood samples taken after two months (T2) from the onset of symptoms (7 subjects), sCD163 levels were decreased compared to T0 (p<0.05), although they did not reach normal values and remained significantly higher than in HD (p = 0.0064) (Fig 2A).